ELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)
SEA940HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)
- Delivery Days Customer12
- Assay Detection Range0.156-10ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Chemokine C-X-C-Motif Receptor 4 (CXCR4) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 0.056ng/mL
- Assay SpecificityThis assay has high sensitivity and excellent specificity for detection of Chemokine C-X-C-Motif Receptor 4 (CXCR4). No significant cross-reactivity or interference between Chemokine C-X-C-Motif Receptor 4 (CXCR4) and analogues was observed.
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Chemokine C-X-C-Motif Receptor 4 (CXCR4). Standards or samples are then added to the ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity. Oglodek EA et al., 2016 Aug, Pharmacol RepRead more
- Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder. Oglodek EA et al., 2015 Dec, Pharmacol RepRead more
- Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression. Oglodek EA et al., 2014 Oct, Pharmacol RepRead more
- The non-alcoholic fraction of beer increases stromal cell derived factor 1 and the number of circulating endothelial progenitor cells in high cardiovascular risk subjects: a randomized clinical trial. Chiva-Blanch G et al., 2014 Apr, AtherosclerosisRead more